Filter announcements
Loading...
J.B. Chemicals and Pharmaceuticals Limited, established in 1976, is one of India's leading pharmaceutical companies. An integrated, publicly-listed organization with a focus on supplying affordable, quality products both in India and internationally, JBCPL is trusted by healthcare professionals globally.
JB Chemicals & Pharma will hold its 50th Annual General Meeting on June 17, 2026, via virtual platforms. The Integrated Annual Report for FY 2025-26 is now accessible to all shareholders, ensuring transparency and stakeholder engagement.
J.B. Chemicals & Pharmaceuticals' FY26 BRSR outlines ambitious ESG goals: carbon neutrality, 100% renewable energy, and water positivity by FY33. FY26 revenue hit ₹4,147.79 Cr, PBT ₹952.33 Cr, and net profit ₹709.47 Cr. A ₹9.30/share dividend was announced.
JBCHEPHARM: The company has received an order from the State Tax Officer, Chennai, imposing a penalty of ₹0.81 Cr. This is for alleged reversal of tax liability related to differences in tax returns vs. books for Apr-19 to Mar-20. The company plans to appeal the order and expects a favorable...
JBCHEPHARM successfully shifts its Registered Office! 🚀 The company's official address is now in Gujarat (Ahmedabad), moving from Maharashtra after receiving approval from the Ministry of Corporate Affairs. **Issue:** Relocation of the company's Registered Office. **Impact:** This is primarily an administrative change. The company's corporate office and core business operations...
Torrent Pharmaceuticals has initiated an open offer to acquire 26.00% of J.B. Chemicals & Pharmaceuticals, comprising 4,17,45,264 shares at INR 1,639.18 per share. This offer totals INR 6,842.8 crore, assuming full acceptance.